|
October 18, 2002
Kivalliq firm puts on gala
PR night for cancer clinic
Evening of hope? Or
evening of hype?
An example of
the kind of three-dimensional image that IDSIs laser mammography device
is able to display on a computer screen.
(IMAGE CAPTURED FROM IDSI WEB SITE)
|
JIM
BELL
A private Kivalliq region
firm, Piruqsaijiit Ltd., will stage a public relations extravaganza in Rankin
Inlet next month to promote their future commercial use of a new U.S. laser
device for detecting breast cancer.
Breast cancer rates among
Inuit women are dramatically lower than in the rest of Canada.
Piruqsaijiit, however,
is proposing to import the machine from Florida and use it to offer breast cancer
screening to anyone in Canada willing and able to pay for it.
Hilary Rebeiro, Piruqsaijiits
general manager, defends the idea with the evangelical zeal of a true believer,
sprinkling his pitch with frequent references to "Inuit elders."
"Why not?" Rebeiro
says. "Robert Kennedy once said, and my Inuit elders kind of share that
view, Some people see things as they are and ask why; we dream of things
that never were and ask why not."
Piruqsaijiit, a management-services
firm that operates as a kind of brain-trust for a family of interconnected property
development firms in the Kivalliq region, decided to diversify into medical
services about three years ago.
Imaging Diagnostics Systems
Inc., or "IDSI," the machines Florida-based manufacturer, has
given Piruqsaijiit exclusive rights to use the machine in Canada, Rebeiro said.
To promote the scheme and
at the same time raise money for breast cancer research, Piruqsaijiit has invited
a long list of people to an $80-a-ticket gala-dinner-concert at Maani Ulujuk
school and the Siniktarvik hotel, in conjunction with a two-day cancer education
campaign.
Theyre calling their
gala dinner the "Evening of Hope."
"Weve invited
the press from the Atlantic to the Pacific, every province, both newspapers
and TV stations. Were starting to see some reaction now," Rebeiro
said.
Dr. Eric Milne, an IDSI
employee Rebeiro calls "one of the foremost radiologists in the world,"
will make presentations and answer questions. School officials have allowed
organizers to use classrooms for their "education" displays, Rebeiro
said.
People who show up will
also get to hear a country-and-western band from Toronto, local throat-singers
and drum-dancers, and public testimonials from breast cancer survivors. A parallel
event at the Siniktarvik hotel will provide "pre-dinner cocktails"
and an open bar for those who want to drink after dinner.
"Its going to
be quite an event. One of the biggest weve had in Rankin," Rebeiro
said.
Piruqsaijiits laser
mammography clinic is an example of the kind of private, for-profit health service
opposed by those who fear the growth of two health systems in Canada
a private system for people who can afford to pay for what they want on demand,
and a lower-quality public system for everyone else.
And Rebeiro doesnt
deny that the service could be offered to affluent queue-jumpers who dont
want to wait in line for whats available in the public system.
But he insists that the
clinic wont lead to a two-tier system in Nunavut because his company
wont turn way anyone who cant pay.
"There is no poor
person, no Inuk woman in the North, who will be denied having her breasts examined
because they cannot afford to pay," Rebeiro says.
Ed Picco, Nunavuts
minister of health and social services, leaves no doubt about where the territorial
government stands on the future of health care in Canada.
"The government of
Nunavut is strongly against any private, for-profit medical care," Picco
said last week.
He also said breast cancer
is rare among Inuit women, and that the number of women the Nunavut government
sends south for diagnostic mammography screens is "minuscule."
"For 85 per cent of
our population, it really isnt an issue. Im not trying to be hard-hearted,
but theyre raising a red flag over something thats not there,"
Picco said.
Health statistics recently
released by the Nunavut government show that other forms of cancer are far more
common among Inuit women. Cancer of the cervix, for example, is a major killer,
affecting 35 per cent of all women diagnosed with cancer in Nunavut.
Another major killer is
lung cancer, striking down Inuit women at a rate 5.3 times higher than the national
average.
Rebeiro says that as lifestyles
change, more Inuit women could suffer breast cancer in the future: "Im
not saying we shouldnt continue to deal with the significant issues with
respect to cervical cancer, thats very important. But should we overlook
this very important tool that weve got?"
But Picco says until government
regulators approve the laser mammography device, Piruqsaijiits proposal
must remain hypothetical.
Neither Health Canada nor
the United States Food and Drug Administration have approved it for routine
diagnostic use in Canada or the U.S. though the FDA has allowed IDSI
to sell its product outside U.S. borders.
"Am I supporting the
particular proposal brought forward by Piruqsaijiit? The answer is no, because
I dont even know if the piece of equipment hes talking about will
ever be able to be used in Canada," Picco says.
Piruqsaijiit, owned by
the group of Kivalliq-based real estate management companies that it sells its
services to, already supplies medical equipment to the Nunavut government "and
anyone else who wants it," Rebeiro said.
He also said the company
helped the Arviat Development Corporation build Arviats new health centre,
which the Arviat firm is now leasing back to the Nunavut government under a
20-year agreement, and that it also leases space to a dental firm.
The new device it wants
to import uses a laser beam that sweeps a womans breast as she lies face
down. It sends a three-dimensional colour image to a computer, which shows many
details that are too small for conventional
x-ray-based mammography
machines to detect.
"Were doing
much earlier detection. Were saving fees. Were having greater clarity
of results. Were having less embarrassment by the women," Rebeiro
says.
He also says the machine
can be used to monitor the progress of breast cancer treatment, because it can
easily be used to find out whether tumours are growing or shrinking.
|